Viromed Medical AG (Q11) — Defensive Interval Ratio

Latest as of September 2025: 50 days

Viromed Medical AG (Q11) has a Defensive Interval Ratio of 50 days as of September 2025. Defensive assets of €8.43 Million (cash €-, short-term investments €8.43 Million, receivables €-) cover 50 days of daily cash needs of €168.75K/day. Check Viromed Medical AG tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

50 days
Days of operational coverage

Defensive Assets

€8.43 Million
Cash + ST Investments + Receivables

Daily Cash Need

€168.75K
Current Liabilities ÷ 365

Current Liabilities

€61.59 Million
EUR

Annual Defensive Interval Ratio for Viromed Medical AG (None–None)

The table below presents the year-by-year Defensive Interval Ratio for Viromed Medical AG from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Q11 market cap overview.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)